1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA WDR44 CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA ING1 CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA RP4-533D7.6 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA RP11-214K3.25 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA TBC1D24 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA SGMS1 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA GPHN CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA GTSE1 CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA CTC-326K19.6 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA SPNS3 CTRPv2 pan-cancer AAC 0.14 4e-05
Download CSV